Christopher Paolino
Oral and Maxillofacial Surgery · Wilmington, DENPI 1467814699
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Straumann USA LLC at 52.9% of the total. Reporting peaked in 2022 at $2,110 and has fallen 87.6% since, to $262 in 2025. Among oral and maxillofacial surgery clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $88.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$2K
- Zimmer Biomet$681
- Nobel Biocare USA$205
- Align Technology, Inc.$202
- Biohorizons Implant Systems Inc.$184
- Zimvie Inc.$153
- plus $335 from 4 others
What the payments were for
- Speaking & faculty fees$1,00027%
- Travel & lodging$89324%
- Food & beverage$1,42038%
- Education$3409%
- Gifts$822%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 14 | $1,975 |
| Zimmer Biomet | 6 | $681 |
| Nobel Biocare USA | 5 | $205 |
| Align Technology, Inc. | 2 | $202 |
| Biohorizons Implant Systems Inc. | 7 | $184 |
| Zimvie Inc. | 3 | $153 |
| AstraZeneca | 1 | $120 |
| Pacira Pharmaceuticals Incorporated | 2 | $116 |
| Johnson & Johnson | 1 | $87 |
| J. Morita USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Invisalign$202
- ULTOMIRIS$120
- EXPAREL$104
- 3DIEMME RealGUIDE$101
How this compares
$3,736 in reported general payments places this provider in the 90th percentile of 32 oral and maxillofacial surgery providers in Delaware.
See all oral and maxillofacial surgery providers in Delaware →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 296 | $1,257 |
| Amoxicillin | 197 | $456 |
| Azithromycin | 24 | $162 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $79 |
| Cephalexin | 12 | $78 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $38 |
| Diazepam | 11 | $10 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Wilmington
- Daniel MearaWilmington$29K
- Fadi KosaWilmington$3K
- Conor CampbellWilmington$531
- Joseph SperaWilmington$397
- Rambod AbediniWilmington$325
- Barry BoydWilmington$290
- David KingWilmington$219
- Peter SubachWilmington$126
- Thomas DoughertyWilmington$68
- Louis RafettoWilmington$58
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.